logo
Select company
Select metric
$ 15.18MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
18
Sector
30
Industry
40
History
46
$ 3.56Close
$ 2.35 - $ 6.36 52-Week Range
Ticker Information

Ticker

OBIO

Company Name

ORCHESTRA BIOMED HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ORCHESTRA BIOMED HOLDINGS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

OBIO - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 15.18M
3/31/2025$ 15.35M
12/31/2024$ 15.28M
9/30/2024$ 15.38M
6/30/2024$ 346K
3/31/2024$ 261K
12/31/2023$ 254K
9/30/2023$ 109.93M
9/30/2022$ 0
6/30/2022$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ORCHESTRA BIOMED HOLDINGS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 166.03M.
  • Over the past 5 years, ORCHESTRA BIOMED HOLDINGS INC's average CF - Equity has been $ 36M.
  • The median CF - Equity for ORCHESTRA BIOMED HOLDINGS INC during this period was $ 7.76M
  • ORCHESTRA BIOMED HOLDINGS INC reached its highest CF - Equity over the past 5 years at $ 166.03M.
  • The lowest CF - Equity recorded by ORCHESTRA BIOMED HOLDINGS INC in the same timeframe $ 0

ORCHESTRA BIOMED HOLDINGS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
CNTB : CONNECT BIOPHARMA HOLDINGS LTD $ 288KPYXS : PYXIS ONCOLOGY INC $ 1.71MNTRB : NUTRIBAND INC $ 5.21MACOG : ALPHA COGNITION INC $ 52.81MORMP : ORAMED PHARMACEUTICALS INC $ -2.85MSTTK : SHATTUCK LABS INC $ -37KALGS : ALIGOS THERAPEUTICS INC $ 101.71MOTLK : OUTLOOK THERAPEUTICS INC $ 34.03MCAMP : CAMP4 THERAPEUTICS CORP $ 76.46MARMP : ARMATA PHARMACEUTICALS INC $ 0

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

OBIO - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 0

Minimum

Dec 31, 2021

$ 166.03M

Maximum

Dec 31, 2020

$ 36M

Average

$ 7.76M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 98.02K with a standard deviation of $ 17.64M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 98.02K
median$ 0
std$ 17.64M